Home » Topics » BioWorld Science

BioWorld Science
RSS

AdPueriVitam discovers novel NMDA receptor antagonists

March 27, 2018

Jiangsu Hengrui Medicine Co., Shanghai Hengrui Pharmaceutical Co. patent factor XIa inhibitors

March 27, 2018

Nippon Kayaku obtains Japanese approval for trastuzumab biosimilar

March 27, 2018

Bayer Pharma divluges new adenosine receptor A2B antagonists

March 27, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

Hemlibra approved in Japan

March 27, 2018

Japanese approval for Orkedia

March 27, 2018

Vitaros end-of-review meeting scheduled by FDA

March 27, 2018

Sanofi seeks U.S. and E.U. approval for sotagliflozin in type 1 diabetes

March 27, 2018

FORMA Therapeutics establishes collaboration with Arpeggio Biosciences

March 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...